Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Warrant Conversion Over-Nine Months Ended February 28, 2007 (Reply)

Looking at the Feb 28th statement of operations (10-Q), the '07 outstanding shares-diluted for 3 and 9 month periods are diferent. One has 410M and the other has 416M. Interesting.

Share
New Message
Please login to post a reply